Unraveling the challenges of pertussis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 2, 2014, Pages 575-576

  Edwards, Kathryn M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TETANUS TOXOID; PERTUSSIS VACCINE;

BORDETELLA PERTUSSIS; HUMAN; NONHUMAN; NOTE; PERTUSSIS; PRIORITY JOURNAL;

ANIMALS; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; WHOOPING COUGH;

EID: 84892602918     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1321360111     Document Type: Note

References (20)

1. Warfel JM, Zimmerman LI, Merkel TJ (2014) Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA 111:787-792.
2. Warfel JM, Beren J, Kelly VK, Lee G, Merkel TJ (2012) Nonhuman primate model of pertussis. Infect Immun 80(4):1530-1536.
3. Edwards KM, Decker MD (2013) Pertussis vaccines. Vaccines , eds Plotkin SA, Orenstein WA, Offit PA (Elsevier, Philadelphia), 6th Ed, pp 447-492.
4. Edwards KM, et al. (1995) Comparison of 13 acellular pertussis vaccines: Overview and serologic response. Pediatrics 96(3 Pt 2):548-557.
5. Decker MD, et al. (1995) Comparison of 13 acellular pertussis vaccines: Adverse reactions. Pediatrics 96(3 Pt 2):557-566.
6. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J (1996) A controlled trial of a two-component acellular, a fivecomponent acellular, and a whole-cell pertussis vaccine. N Engl J Med 334(6):349-355.
7. Greco D, et al.; Progetto Pertosse Working Group (1996) A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 334(6):341-348.
8. Giuliano M, et al. (1998) Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr 132(6):983-988.
9. Gustafsson L, Hessel L, Storsaeter J, Olin P (2006) Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics 118(3):978-984.
10. Salmaso S, et al.; Stage III Working Group (2001) Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: The Italian experience. Pediatrics 108(5):E81.
11. Senzilet LD, et al.; Sentinel Health Unit Surveillance System Pertussis Working Group (2001) Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 32(12):1691-1697.
12. Centers for Disease Control and Prevention (2013) National and state vaccination coverage among adolescents aged 13-17 years ? United States, 2012. August 30, 2013, Morbidity and Mortality Weekly Report 62(34):685-693. Available at www.cdc.gov/mmwr/preview/mmwrhtml/mm6234a1.htm. Accessed December 1, 2013.
13. Misegades LK, et al. (2012) Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 308(20):2126-2132.
14. Witt MA, Katz PH, Witt DJ (2012) Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 54(12):1730-1735.
15. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R (2012) Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 367(11):1012-1019.
16. Sheridan SL, Ware RS, Grimwood K, Lambert SB (2012) Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 308(5):454-456.
17. Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A (1997) Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun 65(6):2168-2174.
18. Ross PJ, et al. (2013) Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis : Towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 9(4):e1003264.
19. Schure RM, et al. (2012) T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children. Clin Vaccine Immunol 19(11):1879-1886.
20. Libster R, Edwards KM (2012) Re-emergence of pertussis: What are the solutions? Expert Rev Vaccines 11(11):1331-1346.